TANG CAPITAL MANAGEMENT LLC

13D and 13G Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.

Issuer % of Class Filed
EyePoint, Inc. 13G
EYPT · 30233G209
 9.6% 10/27/2026
Event 10/20/2026
Skye Bioscience, Inc. 13G
SKYE · 83086J309
 6.0% 10/14/2026
Event 10/7/2026
Atea Pharmaceuticals, Inc. 13G
AVIR · 04683R106
 6.0% 10/6/2026
Event 10/6/2026
Nano Dimension Ltd. 13G
NNDM · 63008G203
 9.1% 8/21/2026
Event 8/19/2026
KalVista Pharmaceuticals, Inc. 13G/A
KALV · 483497103
 0% 8/14/2026
Event 6/30/2026
Capricor Therapeutics, Inc. 13G/A
CAPR · 14070B309
 7.1% 8/14/2026
Event 6/30/2026
Fulcrum Therapeutics, Inc. 13G/A
FULC · 359616109
 10.4% 7/15/2026
Event 7/13/2026
Boundless Bio, Inc. 13G
BOLD · 10170A100
 11.3% 6/29/2026
Event 6/23/2026
Aurinia Pharmaceuticals Inc. 13D/A
AUPH · 05156V102
 10.0% 6/4/2026
Event 6/2/2026
Ventyx Biosciences, Inc. 13G/A
VTYX · 92332V107
 0% 5/15/2026
Event 3/31/2026
Crescent Biopharma, Inc. 13G/A
CBIO · G2545C104
 4.2% 5/15/2026
Event 3/31/2026
Altimmune, Inc. 13G/A
ALT · 02155H200
 0.3% 5/15/2026
Event 3/31/2026
Kezar Life Sciences, Inc. 13D/A
KZR · 49372L209
 0% 5/13/2026
Event 5/11/2026
PureTech Health plc 13G
G7297M101
 5.2% 4/29/2026
Event 4/22/2026
Tarsus Pharmaceuticals, Inc. 13G/A
TARS · 87650L103
 2.8% 2/17/2026
Event 12/31/2025
Spyre Therapeutics, Inc. 13G/A
SYRE · 00773J202
 2.4% 2/17/2026
Event 12/31/2025
Precision BioSciences, Inc. 13G/A
DTIL · 74019P207
 0% 2/17/2026
Event 12/31/2025
Nkarta, Inc. 13G/A
NKTX · 65487U108
 2.1% 2/17/2026
Event 12/31/2025
Keros Therapeutics, Inc. 13G/A
KROS · 492327101
 0% 2/17/2026
Event 12/31/2025
Evolus, Inc. 13G/A
EOLS · 30052C107
 1.9% 2/17/2026
Event 12/31/2025
CytomX Therapeutics, Inc. 13G/A
CTMX · 23284F105
 0% 2/17/2026
Event 12/31/2025
Cybin Inc. 13G/A
HELP · 23256X407
 0% 2/17/2026
Event 12/31/2025
Adicet Bio, Inc. 13G/A
ACET · 007002207
 0.1% 2/17/2026
Event 12/31/2025
ESSA Pharma Inc. 13G/A
EPIX · 29668H708
 0% 11/14/2025
Event 9/30/2025
Compass Therapeutics, Inc. 13G/A
CMPX · 20454B104
 10.0% 11/14/2025
Event 9/30/2025
Bolt Biotherapeutics, Inc. 13G/A
BOLT · 097702203
 3.5% 11/14/2025
Event 9/30/2025
ALX Oncology Holdings Inc. 13G/A
ALXO · 00166B105
 0% 11/14/2025
Event 9/30/2025
Galapagos NV 13G
LKFT · 36315X101
 8.4% 10/29/2025
Event 10/27/2025
Immunocore Holdings plc 13G
IMCR · 45258D105
 5.2% 10/24/2025
Event 10/17/2025
PMV Pharmaceuticals, Inc. 13G
PMVP · 69353Y103
 8.9% 9/23/2025
Event 9/16/2025
HilleVax, Inc. 13D/A
HLVX · 43157M102
 0% 9/19/2025
Event 9/17/2025
ITeos Therapeutics, Inc. 13D/A
ITOS · 46565G104
 100.0% 9/3/2025
Event 8/29/2025
Cargo Therapeutics, Inc. 13D/A
CRGX · 14179K101
 100.0% 8/21/2025
Event 8/19/2025
Reviva Pharmaceuticals Holdings, Inc. 13G/A
RVPH · 76152G100
 4.8% 8/14/2025
Event 6/30/2025
Outlook Therapeutics, Inc. 13G/A
OTLK · 69012T305
 3.4% 8/14/2025
Event 6/30/2025
Elevation Oncology, Inc. 13G/A
ELEV · 28623U101
 4.99% 8/14/2025
Event 6/30/2025
Acelyrin, Inc. 13D/A
SLRN · 00445A100
 0% 5/23/2025
Event 5/21/2025
Allakos Inc. 13D/A
ALLK · 01671P100
 100.0% 5/19/2025
Event 5/15/2025
Journey Medical Corporation 13G/A
DERM · 48115J109
 8.0% 5/15/2025
Event 3/31/2025
Bolt Biotherapeutics, Inc. 13G/A
BOLT · 097702104
 9.9% 5/15/2025
Event 3/31/2025
Adicet Bio, Inc. 13G/A
ACET · 007002108
Amended under CUSIP 007002207 on 2/17/2026
9.9% 5/15/2025
Event 3/31/2025
Kiniksa Pharmaceuticals International, plc 13G
KNSA · G52694109
 5.2% 4/4/2025
Event 3/28/2025
Pliant Therapeutics, Inc. 13D
PLRX · 729139105
 9.6% 3/10/2025
Event 3/3/2025
Monopar Therapeutics Inc. 13G/A
MNPR · 61023L207
 0% 2/14/2025
Event 12/31/2024